Validation of visual estimation of neonatal jaundice in low-income and middle-income countries: a multicentre observational cohort study
Open Access
Abstract
Objective Determine the sensitivity and specificity of neonatal jaundice visual estimation by primary healthcare workers (PHWs) and physicians as predictors of hyperbilirubinaemia. Design Multicentre observational cohort study. Setting Hospitals in Chandigarh and Delhi, India; Dhaka, Bangladesh; Durban, South Africa; Kumasi, Ghana; La Paz, Bolivia. Participants Neonates aged 1–20 days (n=2642) who presented to hospitals for evaluation of acute illness. Infants referred for any reason from another health facility or those needing immediate cardiopulmonary resuscitation were excluded. Outcome measures Infants were evaluated for distribution (head, trunk, distal extremities) and degree (mild, moderate, severe) of jaundice by PHWs and physicians. Serum bilirubin level was determined for infants with jaundice, and analyses of sensitivity and specificity of visual estimations of jaundice used bilirubin thresholds of >260 µmol/L (need for phototherapy) and >340 µmol/L (need for emergency intervention in at-risk and preterm babies). Results 1241 (47.0%) neonates had jaundice. High sensitivity for detecting neonates with serum bilirubin >340 µmol/L was found for ‘any jaundice of the distal extremities (palms or soles) OR deep jaundice of the trunk or head’ for both PHWs (89%–100%) and physicians (81%–100%) across study sites; specificity was more variable. ‘Any jaundice of the distal extremities’ identified by PHWs and physicians had sensitivity of 71%–100% and specificity of 55%–95%, excluding La Paz. For the bilirubin threshold >260 µmol/L, ‘any jaundice of the distal extremities OR deep jaundice of the trunk or head’ had the highest sensitivity across sites (PHWs: 58%–93%, physicians: 55%–98%). Conclusions In settings where serum bilirubin cannot be measured, neonates with any jaundice on the distal extremities should be referred to a hospital for evaluation and management, where delays in serum bilirubin measurement and appropriate treatment are anticipated following referral, the higher sensitivity sign, any jaundice on the distal extremities or deep jaundice of the trunk or head, may be preferred.Keywords
Funding Information
- United States Agency for International Development (GHS-A-00-00020-00)
- United States Agency for International Development (HRN-A-00-90010-00)
- Bill and Melinda Gates Foundation
This publication has 26 references indexed in Scilit:
- Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levelsPediatric Research, 2013
- Validity of neonatal jaundice evaluation by primary health-care workers and physicians in Karachi, PakistanJournal of Perinatology, 2010
- Validation of community health workers' assessment of neonatal illness in rural BangladeshBulletin of the World Health Organization, 2009
- Clinical signs that predict severe illness in children under age 2 months: a multicentre studyThe Lancet, 2008
- Childhood Disability in Low- and Middle-Income Countries: Overview of Screening, Prevention, Services, Legislation, and EpidemiologyPediatrics, 2007
- Home Health Nurse Clinical Assessment of Neonatal JaundiceArchives of Pediatrics & Adolescent Medicine, 2001
- Methodology for a multicenter study of serious infections in young infants in developing countriesThe Pediatric Infectious Disease Journal, 1999
- Skin colour and bilirubin in neonates.Archives of Disease in Childhood, 1989
- The Relationship Between the Cephalo‐Pedal Progress of Clinical Icterus and the Serum Bilirubin Concentration in Newborn Infants Without Blood Type SensitizationActa Obstetricia et Gynecologica Scandinavica, 1975
- Advancement of Dermal Icterus in the Jaundiced NewbornArchives of Pediatrics & Adolescent Medicine, 1969